Reported 2 days ago
This article highlights two high-yield dividend stocks worth investing in: AbbVie and Gilead Sciences. AbbVie boasts an impressive 53-year history of dividend increases and is known for its innovative medicines, particularly in immunology. Gilead Sciences, a leader in HIV treatments, is diversifying its portfolio and has a solid track record of increasing dividends. Both companies are positioned for long-term growth and stability, making them attractive options for income-focused investors.
Source: YAHOO